Newsroom | 24880 results

ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” the “Company,” “we,” “us,” or “our”) (NYSE: CON), the nation’s largest provider of occupational health services, today announced results for its second quarter ended June 30, 2025, the declaration of a cash dividend, and raised guidance for FY 2025. “Concentra delivered strong results in the second quarter, building on our solid start to 2025,” said Keith Newton, Chief Executive Officer of Concentra. “Our resul...

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its second quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Second Quarter 2025 Financial Highlights Net revenues were $152.6 million, an increase of 5.8% year over year, primarily d...

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Total revenue for the second quarter of 2025 was $80.4 million, compared to $164.9 million in the second quarter of 2024. This decline was due to the planned wind-down of migrant-related programs. GAA...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its second quarter 2025 results of operations. “This was a very successful second quarter for Gilead, including the FDA approval for Yeztugo as the world’s first twice-yearly HIV prevention option,” said Daniel O’Day, Gilead’s Chairman and Chief Executive Officer. “Our strong growth this quarter was driven by Biktarvy, Descovy, Trodelvy and Livdelzi, reflecting the diversity of our portfolio. As we enter...

OTTAWA, Ontario--(BUSINESS WIRE)--A new academic study says implementing nurse-to-patient ratios in Ontario’s hospitals would save lives, improve overall patient care and help address a long-standing staffing crisis. Nurse-patient ratios: saving lives and rebuilding nurses’ morale has been co-authored by Dr. Margaret Keith and Dr. Jim Brophy, who since 2017 have produced four studies on working conditions in Ontario’s health care system. The study was commissioned by the Ontario Council of Hosp...

PLANO, Texas--(BUSINESS WIRE)--QinFlow has launched its newest advanced fluid and blood warming solution to meet a critical need in hospital ORs and ICUs....

CANTON, Mass.--(BUSINESS WIRE)--MEDITECH will soon host its premier customer event, MEDITECH LIVE, at its Foxborough, Massachusetts, Conference Center. The three-day leadership summit, scheduled for September 17-19, provides senior-level healthcare executives and clinicians with a unique opportunity to gain knowledge and insight from industry experts on today’s most pressing topics. "Today, healthcare leaders face immense pressure from rising consumer expectations, clinician burnout, and new go...

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, l’impresa che ha creato il sistema di istotripsia Edison® e l’innovativa piattaforma per la terapia con questa tecnica, oggi ha annunciato l’acquisizione della partecipazione di maggioranza guidata dal management da parte di un consorzio di investitori pubblici e privati rinomati globalmente – K5 Global, Bezos Expeditions e Wellington Management nonché altri investitori preesistenti e nuovi. L’operazione assegna a HistoSonics un valore di circa 2,25 mi...

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors...

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, Entwickler des Edison® Histotripsy-Systems und einer neuartigen Histotripsy-Therapieplattform, gab heute bekannt, dass eine Gruppe weltweit anerkannter privater und öffentlicher Investoren, darunter K5 Global, Bezos Expeditions, Wellington Management sowie weitere neue und bestehende Investoren, unter Führung des Managements eine Mehrheitsbeteiligung erworben hat. Die Transaktion bewertet HistoSonics mit rund 2,25 Mrd. USD und versetzt das Unternehmen...